GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
98 hedge funds and large institutions have $798M invested in G1 Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 34 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
98
Holders Change
-1
Holders Change %
-1.01%
% of All Funds
1.94%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
18
Increased
32
Reduced
34
Closed
18
Calls
$248K
Puts
$4.3M
Net Calls
-$4.05M
Net Calls Change
+$327K
Top Buyers
| 1 |
1
JPMorgan Chase & Co
New York
|
$44.1M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$36.4M |
| 3 |
RG
3
Redmile Group
San Francisco,
California
|
$16.2M |
| 4 |
4
Dimensional Fund Advisors
Austin,
Texas
|
$14M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$3.42M |
